Latest period
$605.00M
YoY change
-100.0%
5Y CAGR
-100.0%
Peak year (2024)
$761.00M
Latest annual
$0.00
Stock-Based Compensation history chart for Merck & Co. (MRK) from 1989 to 2025
Latest: $0.00
Stock-Based Compensation growth chart for Merck & Co. (MRK) from 1989 to 2025
Latest: -100.0%
Stock-Based Compensation history table for Merck & Co. (MRK) from 1989 to 2025
| 2025 | $0.00 | -100.0% | −$761.00M | ||
| 2024 | $761.00M | +18.0% | +$116.00M | ||
| 2023 | $645.00M | +19.2% | +$104.00M | ||
| 2022 | $541.00M | +12.9% | +$62.00M | ||
| 2021 | $479.00M | +8.6% | +$38.00M | ||
| 2020 | $441.00M | +5.8% | +$24.00M | ||
| 2019 | $417.00M | +19.8% | +$69.00M | ||
| 2018 | $348.00M | +11.5% | +$36.00M | ||
| 2017 | $312.00M | +4.0% | +$12.00M | ||
| 2016 | $300.00M | +0.3% | +$1.00M | ||
| 2015 | $299.00M | +7.6% | +$21.00M | ||
| 2014 | $278.00M | +0.7% | +$2.00M | ||
| 2013 | $276.00M | -17.6% | −$59.00M | ||
| 2012 | $335.00M | -9.2% | −$34.00M | ||
| 2011 | $369.00M | -27.5% | −$140.00M | ||
| 2010 | $509.00M | +22.5% | +$93.50M | ||
| 2009 | $415.50M | +89.7% | +$196.50M | ||
| 2008 | $219.00M | +3.8% | +$8.00M | ||
| 2007 | $211.00M | +25.6% | +$43.00M | ||
| 2006 | $168.00M | — | +$168.00M | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | $0.00 | ||
| 1998 | $0.00 | — | $0.00 | ||
| 1997 | $0.00 | — | $0.00 | ||
| 1996 | $0.00 | — | $0.00 | ||
| 1995 | $0.00 | — | $0.00 | ||
| 1994 | $0.00 | — | $0.00 | ||
| 1993 | $0.00 | — | $0.00 | ||
| 1992 | $0.00 | — | $0.00 | ||
| 1991 | $0.00 | — | $0.00 | ||
| 1990 | $0.00 | — | $0.00 | ||
| 1989 | $0.00 | — | — |
- 2025$0.00-100.0%
- 2024$761.00M+18.0%
- 2023$645.00M+19.2%
- 2022$541.00M+12.9%
- 2021$479.00M+8.6%
- 2020$441.00M+5.8%
- 2019$417.00M+19.8%
- 2018$348.00M+11.5%
- 2017$312.00M+4.0%
- 2016$300.00M+0.3%
- 2015$299.00M+7.6%
- 2014$278.00M+0.7%
- 2013$276.00M-17.6%
- 2012$335.00M-9.2%
- 2011$369.00M-27.5%
- 2010$509.00M+22.5%
- 2009$415.50M+89.7%
- 2008$219.00M+3.8%
- 2007$211.00M+25.6%
- 2006$168.00M—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
- 1999$0.00—
- 1998$0.00—
- 1997$0.00—
- 1996$0.00—
- 1995$0.00—
- 1994$0.00—
- 1993$0.00—
- 1992$0.00—
- 1991$0.00—
- 1990$0.00—
- 1989$0.00—
Stock-Based Compensation values are taken from Merck & Co.'s reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Merck & Co. (MRK)
Stock-Based Compensation for Merck & Co. (MRK): headline value $605.00M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Merck & Co. (MRK) most recent annual stock-based compensation stands at $0.00 (2025) – plunged 100.0% year-over-year.
Merck & Co. stock-based compensation compound annual growth for the 2020–2025 (5 years) window is -100.0%, with a net decline across the window.
2024 marks the peak stock-based compensation at $761.00M, with the historical low of $0.00 recorded in 1989.
Merck & Co. Stock-Based Compensation by Year
Merck & Co. Stock-Based Compensation 2025: $0.00
Merck & Co. posted stock-based compensation of $0.00 in 2025, plunged 100.0% below 2024.
Merck & Co. Stock-Based Compensation 2024: $761.00M
In 2024, Merck & Co. reported stock-based compensation of $761.00M, grew 18.0% from 2023. This figure represents the highest annual value in the available history.
Merck & Co. Stock-Based Compensation 2023: $645.00M
Merck & Co. stock-based compensation in 2023 was $645.00M, grew 19.2% from 2022.
Merck & Co. Stock-Based Compensation 2022: $541.00M
2022's stock-based compensation for Merck & Co. came in at $541.00M, grew 12.9% from 2021.
Merck & Co. Stock-Based Compensation 2021: $479.00M
Merck & Co. stock-based compensation in 2021 was $479.00M.
See more financial history for Merck & Co. (MRK).
Sector peers by Stock-Based Compensation
Healthcare peers of Merck & Co. (MRK), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $310.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $310.00M
- $0.00
- $0.00
- $0.00
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation